Cover art for Kura Oncology Stock Sells

Kura Oncology Stock Sells

Kura Oncology's stock price falls below $7.43 as first readout shows weak cash position.

Nov 16, 2026

3 cards · 30s · tap to begin

From · · 30s

Kura Oncology Stock Sells

Kura Oncology's stock price falls below $7.43 as first readout shows weak cash position.

In brief

Kura Oncology's stock price falls below $7.43 as first readout shows weak cash position. Kura Oncology's stock is priced below $7.43 due to limited cash cushion and trailing revenue share. Originally reported by Seekingalpha.

Kura Oncology Stock Price

Kura Oncology's stock price sits below $7.43 with fair value at $5.85.

Cash Position Weak

Kura Oncology's cash cushion is about $72 million quarterly, leaving net cash negative by end-2028.

Revenue Share Risk

Revenue Share Risk

Kura trails Revuforj on NPM1 revenue and could lose share if J&J's bleximenib is approved.

At a glance

Kura Oncology's stock is priced below $7.43 due to limited cash cushion and trailing revenue share.

Read the original on Seekingalpha

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on kura oncology and related topics.